Management of COVID-19 in Transplant Recipients Evolved During Pandemic
Therapies used to treat COVID-19 in solid organ transplant recipients shifted since the pandemic began
Therapies used to treat COVID-19 in solid organ transplant recipients shifted since the pandemic began
Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.
During weeks 12-19 of 2020, the incidence of end-stage kidney disease decreased 20% compared with the same period in 2017-2019, according to a COVID-19 supplement to the US Renal Data System 2020 annual data report.
In a study comparing the effect of 9 oral nonsteroidal anti-inflammatory drugs on kidney function, ibuprofen conferred the lowest risk for incident eGFR less than 60 mL/min/1.73 m2 and an eGFR decline of 30% or greater.
Nearly two-thirds of hospitalized patients with COVID-19 and acute kidney injury requiring dialysis died during their hospital stay, a study found.
Lack of timely referrals to nephrologists contribute to racial and ethnic disparities in kidney disease care.
Gout increased the risk of erectile dysfunction in men by 21%.
Study shows that 81% of scrotal ultrasounds for pain demonstrate normal or benign findings.